Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark.
Muna discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson’s. These disorders impact memory, movement, language, behavior and personality resulting in disability and death of millions of patients around the globe.
We focus our groundbreaking science on identifying new medicines to preserve cognition and other brain functions and enhance resilience to neurodegenerative diseases. Our name reflects this focus: Muna means ‘to remember’ in Old Norse.
Company Details
- Employees
- 56
- Founded
- -
- Address
- Nordre Fasanvej 215, Copenhagen (Frederiksberg),capital Region Of Denmark 2000,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://munatherapeutics.com/
- HQ
- Copenhagen (Frederiksberg), Capital Region of Denmark
Muna Therapeutics Questions
Muna Therapeutics's website is https://munatherapeutics.com/
Muna Therapeutics's LinkedIn profile is https://www.linkedin.com/company/muna-therapeutics
Muna Therapeutics has
56 employees.
View email and phone details for 56
employees at Muna Therapeutics.
Muna Therapeutics's industry is
Biotechnology Research
Muna Therapeutics's top competitors are
Capsida Biotherapeutics,
Aviadobio,
Adcendo,
Quralis,
Nmd Pharma A/s,
Nuvig Therapeutics Inc.,
Minervax Aps,
Antag Therapeutics,
Acesion Pharma,
Hemab Therapeutics.
Muna Therapeutics's categories are Biotechnology Research
Muna Therapeutics's founding year is 2020
